New Drug Sunosi Placed in Schedule IV

Oops! Subscribers must be logged in to access this content.

Not A Controlled Substances’ Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the Controlled Substances Module.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson Controlled Substances Module, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Scheduling Actions

New Drug Sunosi Placed in Schedule IV

Joan Flynn

January 13, 2020 at 00:39:05 ET

In a final rule effective Jan. 7, the Drug Enforcement Administration placed the drug solriamfetol (Sunosi) in Schedule IV of the Controlled Substances Act (85 Fed. Reg. 643). The drug is a stimulant intended to improve wakefulness in adults with excessive daytime sleepiness associated with narcolepsy and obstructive sleep apnea, according to manufacturer Jazz Pharmaceuticals. The... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Controlled Substances’ Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the Controlled Substances Module.

Subscription Benefits

Start Your Free Trial

New Drug Sunosi Placed in Schedule IV

My Research Folders

THOMPSON CONTROLLED SUBSTANCES

COMPLIANCE EXPERT

DEA RESOURCES

HELP

CONTACT